2026 Global: Chromatography Market -Competitive Review (2032) report
Description
The 2026 Global: Chromatography Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for chromatography market by geography and historical trend. The scope of the report extends to sizing of the chromatography market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The chromatography market features dominant players like Agilent Technologies, Waters Corporation, Thermo Fisher Scientific, Shimadzu Corporation, and PerkinElmer, which collectively command over 60-80% of global revenues through innovative instruments, consumables, and software ecosystems. These companies lead in liquid chromatography (LC), gas chromatography (GC), and emerging supercritical fluid chromatography (SFC), driven by pharmaceutical, biotech, and environmental testing demands. Agilent Technologies excels in modular LC platforms and sustainable solutions, launching the Infinity III LC Series in October 2025 for enhanced automation. Waters Corporation pioneered ultra-performance LC (UPLC) and released BioResolve Protein A columns in June 2025, boosting sensitivity sevenfold. Thermo Fisher Scientific integrates chromatography with Orbitrap mass spectrometry and acquired Solventum’s purification unit for $4.1 billion in February 2025, expanding bioprocess capabilities. Shimadzu Corporation emphasizes AI-assisted workflows and precision instruments, maintaining strong Asia-Pacific presence. PerkinElmer advances informatics and companion diagnostics, partnering with entities like PathAI.
Complementing these giants, Merck KGaA, Danaher Corporation (encompassing Cytiva and Phenomenex), Bio-Rad Laboratories, Sartorius AG, and Bruker Corporation hold significant shares, focusing on resins, columns, and specialized applications. Merck KGaA and Danaher innovate in biopharma purification; Cytiva and Pall invested $1.5 billion in a new U.S. chromatography plant in March 2025. Bio-Rad supports protein analysis, while Sartorius AG, ranked highly for columns, offers bioprocess solutions like automated bioreactors. Bruker launched the timsMetabo platform in June 2025 for PFAS detection, targeting high-throughput metabolomics. The market, valued at around $10-11 billion in 2025, grows via mergers, patent filings in porous particles, and expansions like Nouryon’s Kromasil facility doubling capacity by 2027 for peptide drugs. Niche firms like Restek, Tosoh, and GL Sciences bolster accessories, but multinationals dominate through R&D and global footprints spanning over 100 countries.
Competitive dynamics center on workflow integration, regulatory compliance, and sustainability amid uncertainties like tariffs and AI disruptions in 2025. Leaders like Agilent and Waters leverage vast portfolios and partnerships, such as Waters-Sartorius for BioSMB systems reducing resin use. Pharma drives over 55% of revenues, with LC pivotal for drug development and proteomics. Emerging trends include oligonucleotide purification via DuPont’s AmberChrom TQ1 resin (May 2025) and Sciex’s ZenoTOF 8600 for tenfold sensitivity gains. Column specialists like MACHEREY-NAGEL and Global Life Sciences Solutions USA LLC rank in niche segments but trail instruments giants. Overall, consolidation via acquisitions and tech stacks positions these ten firms—Agilent, Waters, Thermo Fisher, Shimadzu, PerkinElmer, Merck, Danaher, Bio-Rad, Sartorius, Bruker—to capture growth in a market expanding at 7-9% CAGR through 2030.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for chromatography market by geography and historical trend. The scope of the report extends to sizing of the chromatography market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The chromatography market features dominant players like Agilent Technologies, Waters Corporation, Thermo Fisher Scientific, Shimadzu Corporation, and PerkinElmer, which collectively command over 60-80% of global revenues through innovative instruments, consumables, and software ecosystems. These companies lead in liquid chromatography (LC), gas chromatography (GC), and emerging supercritical fluid chromatography (SFC), driven by pharmaceutical, biotech, and environmental testing demands. Agilent Technologies excels in modular LC platforms and sustainable solutions, launching the Infinity III LC Series in October 2025 for enhanced automation. Waters Corporation pioneered ultra-performance LC (UPLC) and released BioResolve Protein A columns in June 2025, boosting sensitivity sevenfold. Thermo Fisher Scientific integrates chromatography with Orbitrap mass spectrometry and acquired Solventum’s purification unit for $4.1 billion in February 2025, expanding bioprocess capabilities. Shimadzu Corporation emphasizes AI-assisted workflows and precision instruments, maintaining strong Asia-Pacific presence. PerkinElmer advances informatics and companion diagnostics, partnering with entities like PathAI.
Complementing these giants, Merck KGaA, Danaher Corporation (encompassing Cytiva and Phenomenex), Bio-Rad Laboratories, Sartorius AG, and Bruker Corporation hold significant shares, focusing on resins, columns, and specialized applications. Merck KGaA and Danaher innovate in biopharma purification; Cytiva and Pall invested $1.5 billion in a new U.S. chromatography plant in March 2025. Bio-Rad supports protein analysis, while Sartorius AG, ranked highly for columns, offers bioprocess solutions like automated bioreactors. Bruker launched the timsMetabo platform in June 2025 for PFAS detection, targeting high-throughput metabolomics. The market, valued at around $10-11 billion in 2025, grows via mergers, patent filings in porous particles, and expansions like Nouryon’s Kromasil facility doubling capacity by 2027 for peptide drugs. Niche firms like Restek, Tosoh, and GL Sciences bolster accessories, but multinationals dominate through R&D and global footprints spanning over 100 countries.
Competitive dynamics center on workflow integration, regulatory compliance, and sustainability amid uncertainties like tariffs and AI disruptions in 2025. Leaders like Agilent and Waters leverage vast portfolios and partnerships, such as Waters-Sartorius for BioSMB systems reducing resin use. Pharma drives over 55% of revenues, with LC pivotal for drug development and proteomics. Emerging trends include oligonucleotide purification via DuPont’s AmberChrom TQ1 resin (May 2025) and Sciex’s ZenoTOF 8600 for tenfold sensitivity gains. Column specialists like MACHEREY-NAGEL and Global Life Sciences Solutions USA LLC rank in niche segments but trail instruments giants. Overall, consolidation via acquisitions and tech stacks positions these ten firms—Agilent, Waters, Thermo Fisher, Shimadzu, PerkinElmer, Merck, Danaher, Bio-Rad, Sartorius, Bruker—to capture growth in a market expanding at 7-9% CAGR through 2030.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.